Status:
COMPLETED
Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology
Lead Sponsor:
Eugonia
Conditions:
Embryo Viability
Eligibility:
FEMALE
18-49 years
Phase:
PHASE4
Brief Summary
Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo asses...
Detailed Description
Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The aim of the present study was to determine whether emb...
Eligibility Criteria
Inclusion
- patients with at least 4 fertilized oocytes
Exclusion
- patients with less that 4 fertilized oocytes
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT01490515
Start Date
April 1 2010
End Date
December 1 2010
Last Update
December 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eugonia ART Unit
Athens, Attica, Greece, 16561